U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H20IN7O4
Molecular Weight 525.3004
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of I-AB-MECA

SMILES

CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3NCC4=CC=C(N)C(I)=C4

InChI

InChIKey=LOGOEBMHHXYBID-MOROJQBDSA-N
InChI=1S/C18H20IN7O4/c1-21-17(29)14-12(27)13(28)18(30-14)26-7-25-11-15(23-6-24-16(11)26)22-5-8-2-3-10(20)9(19)4-8/h2-4,6-7,12-14,18,27-28H,5,20H2,1H3,(H,21,29)(H,22,23,24)/t12-,13+,14-,18+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H20IN7O4
Molecular Weight 525.3004
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/23487508 | https://www.ncbi.nlm.nih.gov/pubmed/8896425 | https://www.ncbi.nlm.nih.gov/pubmed/10987829 | https://www.ncbi.nlm.nih.gov/pubmed/9037389

I-AB-MECA is iodinated form of parent compound - adenosine derivative, 4-aminobenzyl-5'-N-methylcarboxamidoadenosine (AB-MECA). AB-MECA i a potent agonist of adenosine A3 receptor agonist. 125I-labeled AB-MECA is widely used in in vitro pharmacological studies of adenosine A3 receptor as a refernece ligand. In addition I-AB-MECA is usefull in vitro autoradiography to map adenosine A3 receptor distribution tissues. I-AB-MECA bound to the rat adenosine A1 receptor and canine adenosine A2a receptor.

Originator

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages.
2010-03
Species comparison of adenosine receptor subtypes in brain and testis.
2008-05
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
2003-02
Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization.
2000-10
Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.
1998-06-01
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
1998
[125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
1997-01-16
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.
1996-11-01
125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
1994-05
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
the maximal inhibition of LPS-stimulated TNF-α production by human lung macrophages by AB-MECA was 26 ± 6% at 10 µM
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:15:09 GMT 2025
Edited
by admin
on Mon Mar 31 22:15:09 GMT 2025
Record UNII
9WR19428J3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AB-MECA
Preferred Name English
I-AB-MECA
Common Name English
.BETA.-D-RIBOFURANURONAMIDE, 1-(6-(((4-AMINO-3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-
Systematic Name English
Code System Code Type Description
CAS
152918-27-9
Created by admin on Mon Mar 31 22:15:09 GMT 2025 , Edited by admin on Mon Mar 31 22:15:09 GMT 2025
PRIMARY
FDA UNII
9WR19428J3
Created by admin on Mon Mar 31 22:15:09 GMT 2025 , Edited by admin on Mon Mar 31 22:15:09 GMT 2025
PRIMARY
CHEBI
73285
Created by admin on Mon Mar 31 22:15:09 GMT 2025 , Edited by admin on Mon Mar 31 22:15:09 GMT 2025
PRIMARY
PUBCHEM
9958472
Created by admin on Mon Mar 31 22:15:09 GMT 2025 , Edited by admin on Mon Mar 31 22:15:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID10165159
Created by admin on Mon Mar 31 22:15:09 GMT 2025 , Edited by admin on Mon Mar 31 22:15:09 GMT 2025
PRIMARY